Feature | August 20, 2013

Elekta's Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report

Report cites advantages of Elekta's two systems.

August 20, 2013 — With a score of 93.1 out of 100, Elekta's Leksell Gamma Knife Perfexion system earned the top ranking, receiving high marks for uptime, treatment times and planning speeds, according to KLAS research firm's recently released customer survey, Radiation Therapy 2013: Striving for Accuracy and Upgradeability.

Elekta Infinity radiation treatment system received the No. 2 ranking with a score of 87.8.

The 2013 KLAS report – based on interviews with 169 U.S. providers – states, "[Elekta] field service engineers are very available and perform effective preventive maintenance, as is evidenced by [the Perfexion system's] extremely high uptime rates." The report quotes a chief physicist respondent who says, "Leksell Gamma Knife Perfexion never has downtime. That is partly because of the almost obsessive preventive maintenance done by Elekta. The Perfexion team is really here for us."

The report also cites the rapid treatment times for patients and planning speed: "Perfexion users are very vocal about the precise treatment that works incredibly well for treating brain tumors. Because of the accuracy, the healthy tissue is not affected."

Elekta Infinity earned high scores for reliability in the study, which states, "Providers say that the excellent field support helps with the uptime, and fantastic field support is also one thing that differentiates Elekta from other vendors." A physicist surveyed about Elekta field service people says, "They are the best I have ever had in the field … the Elekta people are just way above and beyond."

The report also cites ease of use of Elekta Infinity as a positive aspect, specifically the automated features and computerization of many functions.

For more information: www.KLASresearch.com

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init